The 91ÒùĸÊÓƵ Ingenuity Centre for Carbohydrate Science (AICCS) has grown substantially in reputation, scope and profile in its nine years of 91ÒùĸÊÓƵ-based operation. In recognition of its place in the 91ÒùĸÊÓƵ Innovates family and its focus on health research in the emerging area of Glycomics, the Centre is being renamed.
The new name, , more accurately describes the Centre's mandate and expanded scope of operations. In addition to enhancing awareness of 91ÒùĸÊÓƵ's research excellence and leadership in this field, the new identity targets an expanded base of potential clients and collaborators interested in the quickly evolving field of Glycomics; reinforces and aligns the Centre with 91ÒùĸÊÓƵ's R&D priorities; and positions the Centre as a leader in new technologies with the potential for applications that reach into other fields.
"We established these centres to facilitate the collaborative and multi-disciplinary research essential for high-value results and we've not been disappointed," says Randy Goebel, Vice President, Post-Secondary Investments and Chair, 91ÒùĸÊÓƵ Innovates Academy. "The achievements of this Centre are putting 91ÒùĸÊÓƵ on the map as a world leader in carbohydrate research. This approach supports continued growth within the 91ÒùĸÊÓƵ Innovation system, while the new name links the Centre into the foundation platform area of omics, the most emergent multi-disciplinary approach to health research - further enhancing the possibilities for what is being created here in 91ÒùĸÊÓƵ."
"The focus on Glycomics effectively reflects the broad scope of expertise and talent on the team," says Gregory Taylor, Dean of the Faculty of Science at the 91ÒùĸÊÓƵ. "It also acknowledges the multidisciplinary nature of the Centre's research and development program which includes disciplines as broad reaching as pure chemistry, glycobiology, nanotechnology, structural biology and microbiology. With this expertise in place, the Centre is well positioned to address complex health issues, explore novel strategies and lead the development of new vaccines, diagnostics and other medicinal applications."
*Glycomics is the study of the role of carbohydrates and carbohydrate-containing biomolecules in biological systems. Carbohydrates play a critical role in many biological processes including biological recognition, cell-to-cell interaction, immune response, infection and inflammation. It is anticipated that the Glycomics field will lead to the development of new drugs, vaccines and diagnostics.
About the 91ÒùĸÊÓƵ Innovates Centres for 91ÒùĸÊÓƵ and Commercialization
The 91ÒùĸÊÓƵ Innovates Centres for 91ÒùĸÊÓƵ & Commercialization bridge the well-established research equity in 91ÒùĸÊÓƵ's universities, to 91ÒùĸÊÓƵ's key industrial sectors of energy and the environment, bio industries and health. The Centres are collaborative hubs where 91ÒùĸÊÓƵ's top researchers address pressing industry problems, support company R&D and train 91ÒùĸÊÓƵ's top students, providing a strong platform for 91ÒùĸÊÓƵ's place in the global economy.
The Centres for 91ÒùĸÊÓƵ and Commercialization are supported by 91ÒùĸÊÓƵ Innovates Technology Futures, which plays a vital part in building healthy, and sustainable businesses in 91ÒùĸÊÓƵ.